# TRX Biosciences (TRX Biosciences Limited) Private limited company registered in Cambridge, classed under “Research and experimental development on biotechnology”. - Company number: 11986839 - Status: Active - Type: Private limited company - Incorporated: 9 May 2019 - Registered office: 280 Babraham Research Campus, Cambridge, CB22 3AT - Location: Cambridge - Activity: Research and experimental development on biotechnology ## Latest filed profit No profit figure in its latest filed accounts. Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers. ## Questions people ask ### What does TRX Biosciences do? Private limited company registered in Cambridge, classed under “Research and experimental development on biotechnology”. ### How much turnover does TRX Biosciences make? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/trx-biosciences-11986839 ### Is TRX Biosciences profitable? TRX Biosciences's profit isn't public: small companies may file without a profit and loss account. ### How many people work at TRX Biosciences? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/trx-biosciences-11986839 ### Who runs and owns TRX Biosciences? Its directors are Robin Bannister, John Brew, Richard John Huston. Its owners are shown to subscribers. ### Where is TRX Biosciences based? Its registered office is 280 Babraham Research Campus, Cambridge, CB22 3AT, in Cambridge. ### When was TRX Biosciences founded? TRX Biosciences Limited was incorporated on 9 May 2019. ### Is TRX Biosciences still trading? The register lists TRX Biosciences Limited as active. ## Timeline Recent filings and changes at Companies House. - 2026-09-17: Micro company accounts made up to 31 December 2025 - 2026-02-18: Registered office address changed from London Bioscience Innovation Centre 2 Royal College Street London NW1 0NH England to 280 Babraham Research Campus Cambridge CB22 3AT on 18… - 2025-10-16: Termination of appointment of Dan Gooding as a director on 10 October 2025 - 2025-06-19: Registered office address changed from The Walbrook Building 25 Walbrook London EC4N 8AF England to London Bioscience Innovation Centre 2 Royal College Street London NW1 0NH on … - 2025-06-02: Micro company accounts made up to 31 December 2024 - 2024-08-29: Micro company accounts made up to 31 December 2023 - 2024-07-16: Memorandum and Articles of Association (and 2 more like it since 12 November 2021) - 2024-03-06: Resolutions (and 4 more like it since 19 March 2021) - 2024-01-30: Statement of capital following an allotment of shares on 18 January 2024 · GBP 71.7051 (and 4 more like it since 11 November 2021) - 2023-07-14: Total exemption full accounts made up to 31 December 2022 - 2023-06-08: Register inspection address has been changed - 2022-09-09: Second filing of a statement of capital following an allotment of shares on 13 May 2022 · GBP 66.4419 (and 2 more like it since 28 March 2022) - 2022-07-08: Total exemption full accounts made up to 31 December 2021 - 2022-05-23: Appointment of Dan Gooding as a director on 13 May 2022 - 2022-01-31: Change of details for Biocopea Limited as a person with significant control on 31 January 2022 - 2021-11-12: Sub-division of shares on 22 October 2021 (and 1 more like it since 12 November 2021) - 2021-09-07: Registered office address changed from Central Point 45 Beech Street London Uk EC2Y 8AD United Kingdom to The Walbrook Building 25 Walbrook London EC4N 8AF on 7 September 2021 - 2021-09-03: Accounts for a dormant company made up to 31 December 2020 - 2021-05-19: Termination of appointment of Gregory Alan Stoloff as a director on 13 May 2021 - 2021-05-12: Appointment of Mr Richard John Huston as a director on 10 May 2021 - 2021-05-12: Appointment of Mr John Brew as a director on 10 May 2021 - 2021-05-12: Appointment of Mr Robin Bannister as a director on 10 May 2021 - 2020-10-20: Total exemption full accounts made up to 31 December 2019 - 2019-06-05: Appointment of Mr Gregory Alan Stoloff as a director on 4 June 2019 - 2019-06-04: Termination of appointment of Philip Edmund Lindsell as a director on 4 June 2019 --- Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/trx-biosciences-11986839